Therapy for Children With Advanced Stage Neuroblastoma
Phase 2 Completed
153 enrolled 12 charts
Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy
Phase 2 Completed
62 enrolled 10 charts
Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study
Phase 2 Completed
45 enrolled 9 charts
AXMUS-C
Phase 2 Completed
52 enrolled 12 charts
Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain
Phase 2 Completed
21 enrolled
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Phase 2 Completed
40 enrolled 15 charts
PAMELA70
Phase 2 Completed
72 enrolled 7 charts
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients
Phase 2 Completed
9 enrolled 9 charts
TICE
Phase 2 Completed
101 enrolled
CURIEFOCALE
Phase 2 Completed
18 enrolled
FORTE
Phase 2 Completed
477 enrolled
TEC-ORL
Phase 2 Completed
13 enrolled
AASUR in High Risk Prostate Cancer
Phase 2 Completed
64 enrolled 7 charts
TBCRC042
Phase 2 Completed
84 enrolled
CAPRI
Phase 2 Completed
123 enrolled
EndoBARR
Phase 2 Completed
30 enrolled 7 charts
A Study on the Use of Fluzoparib Combined With Chemotherapy for Neoadjuvant Treatment of HRD-positive, HR+/HER2- Breast Cancer
Phase 2 Completed
28 enrolled
Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer
Phase 2 Completed
92 enrolled
Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML
Phase 2 Completed
42 enrolled 9 charts
SPRINT
Phase 2 Completed
25 enrolled 9 charts
Flu-Mel-Vel
Phase 2 Completed
54 enrolled 8 charts
IFM-CRd
Phase 2 Completed
46 enrolled
Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)
Phase 2 Completed
57 enrolled
Co-Pa-N
Phase 2 Completed
50 enrolled
INCA
Phase 2 Completed
129 enrolled 7 charts
IFM2012-03
Phase 2 Completed
32 enrolled
IFM2014-04
Phase 2 Completed
64 enrolled
Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia
Phase 2 Completed
19 enrolled
DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma
Phase 2 Completed
20 enrolled
Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial
Phase 2 Completed
43 enrolled
Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation
Phase 2 Completed
35 enrolled
CABA-GCT
Phase 2 Completed
34 enrolled
Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase 2 Completed
42 enrolled
Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma
Phase 2 Completed
24 enrolled
Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer
Phase 2 Completed
101 enrolled 19 charts
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
Phase 2 Completed
100 enrolled 38 charts
FCR
Phase 2 Completed
21 enrolled 9 charts
A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531
Phase 2 Completed
7 enrolled 10 charts
ATEZOLACC
Phase 2 Completed
189 enrolled
Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib.
Phase 2 Completed
40 enrolled
A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC
Phase 2 Completed
28 enrolled
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
Phase 2 Completed
59 enrolled 11 charts
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
Phase 2 Completed
27 enrolled 10 charts
358
Phase 2 Completed
11 enrolled
NeoSACT
Phase 2 Completed
29 enrolled
Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients
Phase 2 Completed
41 enrolled
High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis
Phase 2 Completed
46 enrolled
Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors
Phase 2 Completed
189 enrolled
Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm
Phase 2 Completed
121 enrolled
Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma
Phase 2 Completed
20 enrolled